Olympus Dividends and Buybacks
Dividend criteria checks 3/6
Olympus is a dividend paying company with a current yield of 1.49% that is well covered by earnings. Next payment date is on 5th June, 2026 with an ex-dividend date of 30th March, 2026.
Key information
1.5%
Dividend yield
3.3%
Buyback Yield
| Total Shareholder Yield | 4.8% |
| Future Dividend Yield | 1.7% |
| Dividend Growth | 16.1% |
| Next dividend pay date | 05 Jun 26 |
| Ex dividend date | 30 Mar 26 |
| Dividend per share | n/a |
| Payout ratio | 23% |
Recent dividend and buyback updates
Olympus (TSE:7733) Will Pay A Larger Dividend Than Last Year At ¥30.00
Dec 08
Olympus' (TSE:7733) Upcoming Dividend Will Be Larger Than Last Year's
Nov 24Olympus (TSE:7733) Will Pay A Larger Dividend Than Last Year At ¥30.00
Nov 10Recent updates
Olympus (TSE:7733) Will Pay A Larger Dividend Than Last Year At ¥30.00
Dec 08Olympus' (TSE:7733) Upcoming Dividend Will Be Larger Than Last Year's
Nov 24Olympus (TSE:7733) Will Pay A Larger Dividend Than Last Year At ¥30.00
Nov 10Olympus (TSE:7733) Might Have The Makings Of A Multi-Bagger
Sep 30Earnings Miss: Olympus Corporation Missed EPS By 50% And Analysts Are Revising Their Forecasts
Aug 12A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)
Jul 25Subdued Growth No Barrier To Olympus Corporation's (TSE:7733) Price
Jul 09Olympus (TSE:7733) Seems To Use Debt Quite Sensibly
Jun 17Olympus Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
May 16Does This Valuation Of Olympus Corporation (TSE:7733) Imply Investors Are Overpaying?
Apr 22The Returns At Olympus (TSE:7733) Aren't Growing
Apr 07Investors Appear Satisfied With Olympus Corporation's (TSE:7733) Prospects
Mar 22These 4 Measures Indicate That Olympus (TSE:7733) Is Using Debt Reasonably Well
Feb 01A Look At The Intrinsic Value Of Olympus Corporation (TSE:7733)
Jan 17
Cloud-Powered Endoscopy Innovation Fuels Revenue Growth In The Medical Devices Industry
Approval of AI endoscopy devices in the U.S. and Europe is expected to drive revenue growth through improved clinical outcomes and procedural efficiency.Upcoming Dividend Payment
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 7733's dividends per share have been stable in the past 10 years.
Growing Dividend: 7733's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Olympus Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (7733) | 1.5% |
| Market Bottom 25% (JP) | 1.8% |
| Market Top 25% (JP) | 3.7% |
| Industry Average (Medical Equipment) | 1.2% |
| Analyst forecast (7733) (up to 3 years) | 1.7% |
Notable Dividend: 7733's dividend (1.49%) isn’t notable compared to the bottom 25% of dividend payers in the JP market (1.76%).
High Dividend: 7733's dividend (1.49%) is low compared to the top 25% of dividend payers in the JP market (3.66%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (23%), 7733's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (90.5%), 7733's dividend payments are not well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/10 08:26 |
| End of Day Share Price | 2025/12/10 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Olympus Corporation is covered by 28 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Warren Lau | Aletheia Analyst Network Limited |
| Masahiro Nakanomyo | Barclays |
| Ritsuo Watanabe | BofA Global Research |